Khaitan, NDA on Indo Phyto's $1m buy of Sequent

Wednesday, 24 February 2016 By Prachi Shrivastava Corporate M&A

Khaitan & Co advised Indo Phyto Chemicals on the sale of 51 per cent stake in it to pharma company Sequent Scientific which was advised by Nishith Desai Associates (NDA).

Khaitan Delhi partner Bharat Anand, senior associate Tanvi Kumar and associate Vrinda Agarwal acted for Indo.

NDA Mumbai M&A co-head Simone Reis acted for Sequent.

The acquisition was for Rs 6.85 crore ($1m) and will help Sequent enter the female healthcare segment, according to VC Circle.

Comments

hubba 24 Feb 2016, 11:51

+0 -0

seriously? 1 mill ka deal? reported?

observer 24 Feb 2016, 12:06

+0 -1

iit did have 2 reputable law firms working on the transaction!!!

Guest 24 Feb 2016, 13:10

+2 -0

Good going tan tan!

Anon1 24 Feb 2016, 15:37

+2 -3

Really... Bharat Anand spends his time on 1m deal... KCO Delhi mein din acche nahi hai...

Alias 24 Feb 2016, 17:23

+0 -0

Let's not forget what KCO's rankings have been in the recent M&A reports.

Big Brother Ram 27 Feb 2016, 06:54

+0 -0

1 million dollar my friend. Atleast Bharat is playing in crores, unlike you who is playing in gems.

Millions 24 Feb 2016, 20:00

+1 -0

1M deal. Seriously!

Commenting is closed for this article.